Inhibition of midkine by metformin can contribute to its anticancer effects in malignancies: A proposal mechanism of action of metformin in context of endometrial cancer prevention and therapy-Reference-Cited by-同舟云学术

Inhibition of midkine by metformin can contribute to its anticancer effects in malignancies: A proposal mechanism of action of metformin in context of endometrial cancer prevention and therapy

Published:2020-01 Issue: Volume:134 Page:109420
ISSN:0306-9877
Container-title:Medical Hypotheses
language:en
Short-container-title:Medical Hypotheses

Author:

Karadeniz Zeliha,Aynacıoğlu A. Şükrü,Bilir Ayhan,Tuna M. Yakup

Publisher

Elsevier BV

Subject

General Medicine

Reference76 articles.

1. Metformin use and survival outcomes in endometrial cancer: a systematic review and meta-analysis;Xie;Oncotarget,2017

2. Cancer statistics, 2016;Siegel;CA Cancer J Clin.,2016

3. Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies;Renehan;Lancet,2008

4. Updates on conservative management of endometrial cancer;Corzo;J Minim Invasive Gynecol,2018

5. Preventing endometrial cancer risk in polycystic ovarian syndrome (PCOS) women: could metformin help?;Shafiee;Gynecol Oncol,2014

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Midkine: A Cancer Biomarker Candidate and Innovative Therapeutic Approaches;European Journal of Breast Health;2024-07-01

2. Prognostic and diagnostic effects of high serum midkine levels in patients with hepatocellular carcinoma;Oncology Letters;2024-04-25

3. Prognostic and diagnostic effects of high serum midkine on patients with hepatocellular carcinoma;2023-11-29

4. Role of Midkine in Cancer Drug Resistance: Regulators of Its Expression and Its Molecular Targeting;International Journal of Molecular Sciences;2023-05-14

5. Metformin as a Potential Antitumor Agent;Serbian Journal of Experimental and Clinical Research;2022-11-16